Janssen Cilag S.a.s.

This study looks at whether a tailored physical activity plan can help people with chronic lymphocytic leukemia (CLL) feel better while taking the drug ibrutinib. About 180 participants will be followed for up to 12 months to measure changes in their quality of life, including ph…

This study watches how closely men with advanced prostate cancer follow their prescribed apalutamide treatment over one year. Researchers will track medication adherence and look for patterns that might predict who struggles to stay on track. The goal is to understand real-world …